For you who couldn’t, here is a link to the video recording of the webinar (Click Here).

Highlights:

• The Chinese market, especially the private hospital market, is open for innovative foreign solutions so long as they fit Chinese health economics and care pathways;

• The National Medical Products Administration (NMPA) has jurisdiction, and the regulatory approval processes are similar to the US @FDA;

• China has strong infrastructure for quick R&D iteration; and,

• Our China-based colleagues and contacts can help you meet and investigate potential partners.